Literature DB >> 15338118

Liver transplantation using organs from donors older than 60 years.

Michael Neipp1, Hueseyin Bektas, Rainer Lueck, Dilek Ceylan, Thomas Becker, Juergen Klempnauer, Bjoern Nashan.   

Abstract

At present, it is frequently accepted to expand the organ pool for liver transplantation (LTx) by including livers from critical donors. From 1990 to June 2002 a total of 1,208 LTx were performed. Of those, 67 livers from donors older than 60 years were transplanted to 66 patients, including re-LTx in eight patients. Fourteen patients had malignant diseases (21%). Ten patients had a high urgency status (15%). Median donor age was 65 years (range 61-80 years). Primary graft function was observed in 84%. Patient survival rate at 1 and 5 years was 79% and 62%, and graft survival was 68% and 53%, respectively. No difference was observed in LTx with livers from donors younger than 60 years. Fifteen graft losses occurred during the study. Surgical complications were observed in 23 patients (34%). The outcome of LTx with livers from donors older than 60 years is satisfactory and is comparable to results of LTx with livers from donors younger than 60 years. The frequency of vascular complications and cholestasis syndrome is not increased.

Entities:  

Mesh:

Year:  2004        PMID: 15338118     DOI: 10.1007/s00147-004-0735-2

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  2 in total

Review 1.  Using old liver grafts for liver transplantation: where are the limits?

Authors:  Carlos Jiménez-Romero; Oscar Caso Maestro; Félix Cambra Molero; Iago Justo Alonso; Cristina Alegre Torrado; Alejandro Manrique Municio; Jorge Calvo Pulido; Carmelo Loinaz Segurola; Enrique Moreno González
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury.

Authors:  Paulo N Martins; Sue Chang; Basant Mahadevapa; Ann-Britt Martins; Patricia Sheiner
Journal:  HPB (Oxford)       Date:  2011-03       Impact factor: 3.647

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.